‘Better quantitative understanding of the trajectories of GBS carriage during pregnancy is essential for the design of informative epidemiological studies.’.

Maternal colonization by Group B Streptococcus (GBS) can lead to severe infection in neonates and has also been associated with prematurity and stillbirth. Bronner P. Gonçalves’s comments on research into maternal Group B Strep colonisation. Bronner P. Gonçalves’s research, recently published in the iScience Journal, ‘Inferring longitudinal patterns of group Read more…

Photo by CDC on Unsplash

MinervaX announces 72M EUR financing to advance development of novel vaccine against Group B Streptococcus

MinervaXApS, a privately held Danish biotechnology company developing a novel vaccine against Group B Streptococcus (GBS), today announces the successful completion of a 72 million EUR financing round. The equity financing of 22 million EUR was co-led by new investors Trill Impact Ventures and Pureos Bioventures and includes existing investors Read more…

World Meningitis Day 2022 Logo

World Meningitis Day

On the 5th of October, we joined organisations and individuals around the globe to mark World Meningitis Day 2022. Together, meningitis and neonatal sepsis are the second biggest infectious cause of death in children under five. They can kill in hours, have life-long implications for those that do survive, and have Read more…